IRIS
MORETTA, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 59.976
AS - Asia 5.037
NA - Nord America 1.733
SA - Sud America 373
AF - Africa 85
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 67.209
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 59.040
SG - Singapore 2.356
US - Stati Uniti d'America 1.623
CN - Cina 1.335
VN - Vietnam 822
FR - Francia 487
BR - Brasile 248
HK - Hong Kong 177
FI - Finlandia 109
DE - Germania 93
JP - Giappone 68
CH - Svizzera 65
MX - Messico 65
GB - Regno Unito 51
AR - Argentina 50
BD - Bangladesh 43
IN - India 35
IQ - Iraq 31
NL - Olanda 30
PH - Filippine 28
CA - Canada 27
ID - Indonesia 27
EC - Ecuador 19
ZA - Sudafrica 17
PK - Pakistan 16
RU - Federazione Russa 16
TH - Thailandia 15
CO - Colombia 12
IE - Irlanda 12
MA - Marocco 12
UZ - Uzbekistan 11
VE - Venezuela 11
PY - Paraguay 10
CL - Cile 9
CR - Costa Rica 8
DZ - Algeria 8
ES - Italia 8
KE - Kenya 8
PE - Perù 8
SA - Arabia Saudita 8
UA - Ucraina 8
RO - Romania 7
TW - Taiwan 7
EG - Egitto 6
JO - Giordania 6
MY - Malesia 6
TN - Tunisia 6
AL - Albania 5
AT - Austria 5
BG - Bulgaria 5
PL - Polonia 5
PT - Portogallo 5
SE - Svezia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
GA - Gabon 4
IR - Iran 4
OM - Oman 4
PS - Palestinian Territory 4
SN - Senegal 4
TR - Turchia 4
AO - Angola 3
AU - Australia 3
BO - Bolivia 3
LB - Libano 3
MM - Myanmar 3
NP - Nepal 3
BY - Bielorussia 2
CD - Congo 2
CG - Congo 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DJ - Gibuti 2
GF - Guiana Francese 2
GR - Grecia 2
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
KG - Kirghizistan 2
LT - Lituania 2
ML - Mali 2
SI - Slovenia 2
SV - El Salvador 2
TL - Timor Orientale 2
BB - Barbados 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BW - Botswana 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
HN - Honduras 1
HU - Ungheria 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
Totale 67.194
Salva come PNG Salva come JPEG
Città #
Genova 40.047
Genoa 10.845
Rapallo 4.521
Vado Ligure 3.395
Singapore 1.085
San Jose 829
Lauterbourg 460
Ho Chi Minh City 242
Hanoi 175
Hong Kong 164
Beijing 163
Ashburn 155
New York 115
Helsinki 109
Bordighera 108
Frankfurt am Main 83
Council Bluffs 75
Santa Clara 66
Tokyo 65
Zurich 65
Mexico City 41
Haiphong 39
Da Nang 36
Milan 33
Tianjin 33
Los Angeles 25
Amsterdam 21
Des Moines 19
Shanghai 17
Biên Hòa 16
Baghdad 15
City of London 15
Orem 15
Chicago 13
Bangkok 12
Hải Dương 12
Ninh Bình 12
São Paulo 12
Cardiff 11
Dublin 11
Montreal 10
Mumbai 10
Brasília 9
Dallas 9
Johannesburg 9
Tashkent 9
Can Tho 8
London 8
Valenza 8
Denver 7
Dhaka 7
Guangzhou 7
Jakarta 7
Nairobi 7
Paris 7
San José 7
Toronto 7
Amman 6
Atlanta 6
Chennai 6
Hưng Yên 6
Lima 6
Porto Alegre 6
Quận Ba 6
Rome 6
Thái Nguyên 6
Vĩnh Long 6
Buffalo 5
Bắc Ninh 5
Guayaquil 5
Karachi 5
Manchester 5
Marseille 5
Medellín 5
Nuremberg 5
Quảng Ngãi 5
Ribeirão das Neves 5
Rio de Janeiro 5
Thái Bình 5
Wuhan 5
Baku 4
Buenos Aires 4
Bắc Giang 4
Caracas 4
Dakar 4
Guarulhos 4
Ha Long 4
Hangzhou 4
Kyiv 4
Lahore 4
Madrid 4
Manila 4
Pasadena 4
Poplar 4
Quezon City 4
Ribeirão Preto 4
Santiago 4
Shenyang 4
Shenzhen 4
Stockholm 4
Totale 63.516
Salva come PNG Salva come JPEG
Nome #
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function 250
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 245
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 232
Activating KIRs and NKG2C in viral infections: Toward NK cell memory? 231
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 226
Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation. 225
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 221
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 220
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 213
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches. 212
GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues. 211
Both CD133(+) and CD133(-) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity 209
2B4 functions as a co-receptor in human NK cell activation 208
NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia 203
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 201
Late development of FcεRγneg adaptive natural killer cells upon human cytomegalovirus reactivation in umbilical cord blood transplantation recipients 200
Bridging innate NK cell Functions with Adaptive Immunity. 199
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors 199
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 198
Features of Memory-Like and PD-1+ Human NK Cell Subsets 197
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 196
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. 193
NK/DC crosstalk in anti-viral response. 193
B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2. 192
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 192
Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. 188
X-linked lymphoproliferative disease: the dark side of 2B4 function. 187
Haploidentical Haematopoietic Stem Cell Transplantation: Role of NK Cells and Effect of Cytomegalovirus Infections 186
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 186
Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells 184
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 184
Function and specificity of human natural killer cell receptors. 184
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing 184
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? 182
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 182
A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand. 181
A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s). 181
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor 181
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. 180
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NK p30 180
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells 180
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. 179
CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. 178
Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. 178
Markers and function of human NK cells in normal and pathological conditions 177
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor 176
NK cells and their receptors during viral infections. 175
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. 175
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors. 175
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 172
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 172
Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4 + T helper cells and CD4 + CD25hi T regulatory cells 172
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 171
Identification of NKp80, a novel triggering molecule expressed by human NK cells. 170
Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture. 170
A high-resolution view of NK-cell receptors: structure and function. 170
Multi-directional cross-regulation of NK cell function during innate immune responses. 169
Learning how to discriminate between friends and enemies,a lesson from Natural Killer cells 169
Human NK receptors: from the molecules to the therapy of high risk leukemias. 169
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. 169
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor 168
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 168
Human NK cells and NK receptors 168
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 168
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors 167
Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells 167
Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). 167
Alloreactive natural killer cells in targeting high-risk leukaemias. 167
KIR and KIR ligand polymorphism: a new area for clinical applications? 167
Natural killer cells and dendritic cells: rendezvous in abused tissues. 166
CIS is a negative regulator of IL-15-mediated signals in NK cells 166
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 166
Stimulatory receptors in NK and T cells. 165
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction 165
Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias. 164
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. 164
Human Natural Killer Cells exposed to IL-2, IL12, IL-18 or IL-4 differently modulate priming of naïve T cells by monocyte-derived Dendritic Cells. 164
Impact of HCMV Infection on NK Cell Development and Function after HSCT. 164
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. 163
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 162
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 161
Surface receptors that regulate the NK cell function: beyond the NK cell scope. 160
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis 160
Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). 160
Cellular ligands for activating NK receptors 159
Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. 159
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. 159
CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. 159
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. 159
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. 158
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 158
Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies 158
A monoclonal anti-DC1 antibody selectivity inhibits the generation of effector T cells mediating specific cytolytic activity. 157
Unravelling natural killer cell function: triggering and inhibitory human NK receptors. 156
Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases. 156
Imatinib and nilotinib off-target effects on human NK cells, monocytes, and M2 macrophages 156
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. 155
Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses 155
Oxysterol mixture and, in particular, 27-hydroxycholesterol drive M2 polarization of human macrophages 155
Overview of the Soluble and Membrane-bound Tumor Factors Limiting NKmediated Immune Surveillance 155
Totale 17.953
Salva come PNG Salva come JPEG
Categoria #
all - tutte 194.133
article - articoli 172.441
book - libri 0
conference - conferenze 7.761
curatela - curatele 0
other - altro 0
patent - brevetti 11.646
selected - selezionate 0
volume - volumi 2.285
Totale 388.266
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021932 0 0 0 0 0 0 0 0 0 370 268 294
2021/20226.108 179 498 640 659 277 297 379 1.421 220 550 259 729
2022/20235.521 631 317 52 576 895 1.118 2 397 1.014 34 410 75
2023/20242.479 123 419 69 287 229 353 107 163 194 77 145 313
2024/20257.531 126 644 317 488 1.283 711 678 991 319 342 668 964
2025/202611.634 1.447 350 787 1.045 1.613 1.553 2.362 597 830 1.050 0 0
Totale 67.773